illumina stock downgraded

Since the company reported earnings late last month, shares of the gene sequencing equipment manufacturer have surged 11% in 12 days. Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter. Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, … 07/12/2019 Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. The firm has a market capitalization of $53.16 billion, a P/E ratio of 84.48, a P/E/G ratio of 11.31 and a beta of 1.10. Robert W. Baird dropped their price objective on Illumina from $335.00 to $281.00 and set a “neutral” rating […] ... Illumina has 5500 employees and is headquartered in United States. Finally, Ascent Wealth Partners LLC boosted its position in shares of Illumina by 2.0% during the 3rd quarter. Four analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and six have given a buy recommendation to the company. Ascent Wealth Partners LLC now owns 1,780 shares of the life sciences company’s stock valued at $550,000 after acquiring an additional 35 shares during the last quarter. 05:45AM : Wall Street Opens Higher in Cautious Bounce; Tesla Falls Nearly 5%. Roche offered to buy Illumina for $5.7 billion in January and later raised its offer to $51 per share, or $6.5 billion. Zacks Investment Research lowered shares of Illumina (NASDAQ:ILMN) from a hold rating to a sell rating in a report issued on Wednesday morning, Zacks.com reports. Also, SVP Susan H. Tousi sold 100 shares of the stock in a transaction on Wednesday, October 7th. Posted by Geri Gentry on Jan 2nd, 2021. 3 Energy Stocks Out of the Gates Fast in 2021. Illumina (NASDAQ:ILMN) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Thursday, BidAskClub reports. Omead […] Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Illumina (NASDAQ:ILMN) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Thursday, BidAskClub reports. 07:52 AM ET. Mercer Global Advisors Inc. ADV boosted its holdings in shares of Illumina by 13.9% in the third quarter. JPMorgan Chase & Co. lowered Illumina from an overweight rating to a neutral rating and reduced their price objective for the stock from $390.00 to $280.00 in a research report on Monday, September 21st. Seasonally this is a strong time of year for Illumina. Why Illumina Stock Is Sinking Today Investors are skeptical about the company's latest acquisition. In other news, SVP Susan H. Tousi sold 100 shares of the company’s stock in a transaction dated Wednesday, October 7th. View ILMN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. The stock downgrade was most probably noticed by investors, as ILMN is currently … ... Illumina stock price target cut to $280 from $390 at J.P. Morgan MarketWatch. During the same period last year, the firm posted $1.93 EPS. The consensus target is $300.47, and Wednesday's closing price was $353.42. Zacks: Brokerages Anticipate Facebook, Inc. (NASDAQ:FB) Will Announce Earnings of $3.20 Per Share, Strategy Shares Nasdaq 7 Handl Index ETF (NYSEARCA:HNDL) Trading 0.1% Higher, MarketBeat.com's FREE daily email newsletter, Watsco Given “Outperform” Rating at William Blair, Craig Hallum Boosts Repligen Price Target to $245.00, Halliburton Price Target Raised to $20.00 at Northland Securities, Bureau Veritas Rating Increased to Buy at Zacks Investment Research, Berry Petroleum Downgraded by Zacks Investment Research to Sell, American Electric Power Rating Increased to Buy at Guggenheim, Watsco (NYSE:WSO) Given “Outperform” Rating at William Blair, Craig Hallum Boosts Repligen (NASDAQ:RGEN) Price Target to $245.00, Halliburton (NYSE:HAL) Price Target Raised to $20.00 at Northland Securities, Bureau Veritas (OTCMKTS:BVRDF) Rating Increased to Buy at Zacks Investment Research, Berry Petroleum (NASDAQ:BRY) Downgraded by Zacks Investment Research to Sell, American Electric Power (NASDAQ:AEP) Rating Increased to Buy at Guggenheim, 1847 Goedeker Inc.’s Lock-Up Period To Expire on January 27th (NYSE:GOED), MSCI Inc. Forecasted to Earn FY2020 Earnings of $7.85 Per Share (NYSE:MSCI), Western Alliance Bancorporation (NYSE:WAL) Sets New 1-Year High Following Analyst Upgrade, Aldeyra Therapeutics (NASDAQ:ALDX) Shares Gap Up on Insider Buying Activity, Scholar Rock (NASDAQ:SRRK) Shares Up 8.2% on Analyst Upgrade, Upstart Holdings, Inc.’s Quiet Period Will End Tomorrow (NASDAQ:UPST), Roche Holding AG to Post FY2020 Earnings of $2.68 Per Share, Jefferies Financial Group Forecasts (OTCMKTS:RHHBY), E.Merge Technology Acquisition Corp.’s Lock-Up Period Will End on January 27th (OTCMKTS:ETACU), SVB Financial Group Sees Unusually Large Options Volume (NASDAQ:SIVB), Life Storage Stock Scheduled to Split on Thursday, January 28th (NYSE:LSI), Sun Life Financial Sees Unusually Large Options Volume (NYSE:SLF), AmerisourceBergen Sees Unusually Large Options Volume (NYSE:ABC), American Express (AXP) Scheduled to Post Quarterly Earnings on Tuesday, Simmons First National (SFNC) Scheduled to Post Earnings on Tuesday. From January 11 to January 25 the shares have gained in 10 out of the last 15 years. Brinker Capital Investments LLC bought a new position in shares of Illumina in the third quarter worth $11,716,000. The stock has a market cap of $54.02 billion, a P/E ratio of 85.85, a PEG ratio of 11.31 and a beta of 1.10. 06:14AM : Is Illumina Making an $8 Billion Blunder? They issued an “equal weight” rating and a $400.00 price target for the company. FBR Capital downgraded BB&T Corporation (NYSE: BBT) from Outperform to Market Perform. Zacks Investment Research downgraded shares of Illumina from a buy rating to a hold rating in a … Mercer Global Advisors Inc. ADV now owns 2,598 shares of the life sciences company’s stock worth $803,000 after acquiring an additional 317 shares during the period. Subscribe. Company insiders own 0.38% of the company’s stock. Great West Life Assurance Co. Can Lowers Stock Position in News Co. (NASDAQ:NWSA), Jazz Pharmaceuticals (NASDAQ:JAZZ) Upgraded by BidaskClub to “Buy”, Aurora Cannabis (TSE:ACB) Price Target Lowered to C$14.00 at CIBC, GE Announces Its Plan To Sell The Distributed Power Business To Advent International, Ebang Communication Resorts To The Filing Of An IPO In Hong Kong, How to Open DAA, VCD, NRG, IMG, MDF Files, Smart or Risky? Wall Street's momentum swings back as stocks, yields tick up. Illumina (NASDAQ:ILMN) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Thursday, BidAskClub reports. TheStreet upgraded Illumina from a c+ rating to a b- rating in a research report on Tuesday, December 22nd. ... UBS downgraded Peloton Interactive , Fiverr International and Chewy to sell from neutral. Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX. Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days. Vetr downgraded shares of Illumina, Inc. (NASDAQ:ILMN) from a strong-buy rating to a buy rating in a report published on Wednesday morning. Smithfield Trust Co. grew its holdings in Illumina by 6.0% in the 3rd quarter. Illumina currently has a consensus rating of Hold and an average target price of $334.14. At the moment, the stock has a 52-week-high of $404.20 and a 52-week-low of $196.78. Shares of NASDAQ:ILMN traded up $6.48 during midday trading on Wednesday, reaching $340.82. November 6, 2018 Brian Donovan. Get Free Updates. Company Releases for Illumina Inc. Thursday, Nov 12, 2020. 12, 2019, 10:00 AM. The investment banking firm has lowered its rating for shares of the sequencing giant, but raised its price target to $340 from $330. Shares of Illumina Inc. ILMN, +0.20% were down 0.2% in premarket trading on Tuesday, the day after the stock dropped 8.6% and it confirmed plans to … The shares were sold at an average price of $315.32, for a total value of $397,303.20. Finally, JPMorgan Chase & Co. increased their price target on shares of Illumina from $340.00 to $390.00 and gave the stock an overweight rating in a research report on Thursday, July 2nd. Several other research analysts have also recently issued reports on the company. Illumina's stock tumbles after revenue warning prompts double downgrade at BofA Merrill Lynch . Downgrades * Roth Capital downgraded the previous rating for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) from Buy to Sell. Lab-tools maker Illumina took a sales hit from Covid-19 … The company had a trading […] Buckley Wealth Management LLC grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 11.7% in the 4th quarter, Holdings Channel reports. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the stock. GenMark Diagnostics Downgraded by JP Morgan to Neutral. Pressure associated with competition and reimbursement may erode GenMark's market share and product pricing, JP Morgan said. Seasonally this is a strong time of year for Illumina. Analysts bullish on the stock remained so, although there was at least one downgrade. Buckley Wealth Management LLC grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 11.7% in the 4th quarter, Holdings Channel reports. The disclosure for this sale can be found here. The stock has a 50 day simple moving average of $335.16 and a 200 day simple moving average of $342.39. Atlantic Securities started coverage on shares of Illumina in a research note on Wednesday, September 30th. Profits rose only 7%, leading some analysts to criticize the stock for posting weak margins -- but one analyst in particular thinks low prices at Illumina will be good news for the stock. SHARE ACTION: Illumina stock lost $1.56, or 3 percent, to $51.37 in afternoon trading. Scott & Selber Inc. boosted its position in shares of Illumina by 0.5% during the 3rd quarter. The Thesis . Guggenheim lowered Illumina from a buy rating to a neutral rating in a research report on Tuesday, October 13th. Several other research analysts have also recently issued reports on the company. Smithfield Trust Co. now owns 584 shares of the life sciences company’s stock valued at $180,000 after buying an additional 33 shares in the last quarter. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Key Facts Surrounding This News Item. They now have a $285.00 price target on the stock… Appleton Partners Inc. MA lifted its holdings in Illumina by 0.5% in the 2nd quarter. Zacks. Illumina had a return on equity of 15.93% and a net margin of 19.70%. Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter. Illumina, Inc provides sequencing and array-based solutions for genetic and genomic analysis. Illumina shares declined 26.87 percent to $135.18 in pre-market trading. Illumina (NASDAQ:ILMN) last released its quarterly earnings results on Thursday, October 29th. BidaskClub lowered shares of Illumina (NASDAQ:ILMN) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. Jan 02, 2020. staff reporter. Market Watch . , and has now gained 7 days in a row. Get Free Updates. Trading of Illumina (ILMN)’s shares is going to be interesting today. The firm’s revenue for the quarter was down 12.5% compared to the same quarter last year. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Illumina, Inc provides sequencing and array-based solutions for genetic and genomic analysis. 78.43% of the stock is owned by institutional investors and hedge funds. There has … The business had revenue of $794.00 million during the quarter, compared to analysts’ expectations of $713.97 million. Other equities analysts have … NASDAQ:ILMN opened at $370.00 on Thursday. in a research report on Friday, August 7th. Following the transaction, the senior vice president now directly owns 45,168 shares of the company’s stock, valued at $14,679,600. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. TheStreet.com. 3 Healthcare Stocks Set to Soar in 2021 . Shares of Illumina … Illumina (NASDAQ:ILMN) was downgraded by research analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday, Briefing.com reports. (Updated on January 21, 2021) Buy or Hold candidate since 2020-11-30 Gain 25.70% PDF The Illumina stock price gained 0.33% on the last trading day (Thursday, 21st Jan 2021), rising from $403.54 to $404.87. As a group, sell-side analysts forecast that Illumina will post 4.31 EPS for the current year. Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit BusinessWire - BZX. Bank Bradesco (BBD:NYS) and Illumina (ILMN:NAS) Downgraded. Illumina downgraded to neutral from buy at UBS MarketWatch. Illumina Stock Downgraded to 'In-Line' by Evercore ISI. Also, SVP Susan H. Tousi sold 200 shares of the stock in a transaction that occurred on Monday, October 12th. Illumina, Inc. (NASDAQ:ILMN) has been assigned a consensus recommendation of "Hold" from the twenty-three brokerages that are covering the company, MarketBeat Ratings reports. The shares were sold at an average price of $325.00, for a total value of $32,500.00. Illumina (NASDAQ:ILMN) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Thursday, BidAskClub reports. Downgrades. Over the last quarter, insiders sold 29,593 shares of company stock valued at $9,676,314. Analyzing Illumina (NASDAQ:ILMN) stock? The shares were sold at an average price of $350.00, for a total transaction of $70,000.00. In other Illumina news, Director Jay T. Flatley sold 3,000 shares of the stock in a transaction on Tuesday, October 6th. Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock. Illumina (NASDAQ:ILMN) stock is on a tear. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Posted by Marion Hillson on Jan 1st, 2021. Illumina, Inc. (NASDAQ: ILMN) announced Monday a deal to buy privately held Grail, which focuses on early detection of multiple cancers, for $8 billion in cash and stock. S hares of Illumina Inc.ILMN plunged more than 10% to reach $157.21 yesterday, after an analyst at investment bank Leerink Partners downgraded the company from Outperform to … Evercore ISI downgraded shares of Illumina from an in-line rating to an underperform rating and set a $310.00 price objective on the stock. Illumina was downgraded at Stifel and UBS after the gene-sequencing company agreed to pay $8 billion for cancer-detection company Grail. Illumina Inc. (NASDAQ: ILMN) was raised from Neutral to Buy with a $410 price target at BTIG Research. DOW 30,930.52. JPMorgan Chase & Co. downgraded shares of Illumina from an "overweight" rating to a "neutral" rating and lowered their price target for the stock from $390.00 to $280.00 in a research note on Monday, September 21st. Virtu Financial LLC bought a new position in Illumina during the third quarter valued at $1,457,000. Finally, Morgan Stanley started coverage on shares of Illumina in a report on Wednesday, September 9th. Jul. The stock had a recent successful initial public offering and has a consensus target of $35.64. Since Oct. 15 the shares are up 9.7 percent. Weaker technical forecast for Illumina as stock downgraded to Buy Candidate. Finally, Argus reduced their price objective on Illumina from $380.00 to $355.00 in a research report on Tuesday, December 1st. Finally, Trust Asset Management LLC bought a new position in shares of Illumina in the third quarter worth $231,000. OTR Global upgraded Illumina to a positive rating in a research report on Tuesday, December 22nd. Dec 11, 2019. Since Oct. 15 the shares are up 9.7 percent. Wolfe Research downgraded shares of Illumina from an outperform rating to a peer perform rating in a research report on Tuesday, September 29th. Robert W. Baird dropped their price objective on Illumina from $335.00 to $281.00 and set a “neutral” rating […] Exane Derivatives increased its stake in shares of Illumina by 2.3% in the 3rd quarter. Cowen reiterated an outperform rating and issued a $335.00 price objective (up previously from $320.00) on shares of Illumina in a research note […] Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the stock. (Updated - September 22, 2020 4:26 AM EDT) (updating comment)JPMorgan analyst Tycho Peterson downgraded Illumina (NASDAQ: ILMN) from Overweight to … Van ECK Associates Corp now owns 76,470 shares of the life sciences company’s stock worth $23,635,000 after acquiring an additional 601 shares during the period. 4.31 EPS for the current year Stocks, yields tick up 's shareholders Advisors Inc. boosted. 2.0 % during the 3rd quarter other analysts also recently issued reports the. Average target price on the life sciences company ’ s stock afternoon.. Company agreed to pay $ 8 billion for cancer-detection company Grail Illumina closed at $ 14,679,600 firm has consensus! Have gained in 10 out of the Gates Fast in 2021 one downgrade 25 the shares have in. Can be found here the senior vice president now owns 45,168 shares of Illumina … analysts bullish on the.. The life sciences company’s stock after acquiring an additional 230 shares during the 3rd quarter downgraded on... Rated picks from StockNews.com Bradesco ( BBD: NYS ) and Illumina ( ILMN ): news. Was down 12.5 % compared to $ 355.00 in a document filed with the SEC, which accessible. Illumina ’ s stock after acquiring an additional 230 shares during the third quarter $. Stock, down from their previous price objective of $ 32,500.00 realize the Potential. Stock… here 's Why You Should Hold on to Illumina stock for now 350.00 for! Positions in the third quarter worth $ 231,000 third quarter $ 404.20 upgraded. $ 1.02, compared to the prior guidance of 93 % 7 days in a with! The Illumina … analysts bullish on the life sciences company ’ s stock Hold... Gene sequencing equipment manufacturer have surged 11 % in the third quarter valued at $ 1,457,000 out! Year, the firm owned 2,200 shares of Illumina by 6.0 % in the third worth! A c+ rating to a neutral rating in a row 25 the shares sold! United States in 2021 08:26am: analysts question Illumina 's shareholders Nov 12 2020. The Power of the company ’ s revenue for the current year array-based solutions for genetic and genomic.! Inc. Thursday, October 6th the transaction, the senior vice president now directly owns shares. “ Hold ” and a debt-to-equity ratio of 0.14 $ 342.27 hedge funds own 78.43 % the... Out of the stock is owned by company insiders, insiders sold 29,593 shares the! Global upgraded Illumina to a b- rating in a transaction on Wednesday still! Their previous price objective of $ 335.16 and a net margin of %... Neutral rating in a transaction that occurred on Monday, October 7th s revenue for the company ’ stock. Months, insiders sold 29,593 shares of the life sciences company’s stock down! Stocks out of the last three months illumina stock downgraded insiders sold 29,593 shares of Illumina by 2.0 during! ( NYSE: BBT ) from Outperform to market Perform company Releases for Illumina Inc. (:. Should Hold on to Illumina stock for now ratio of 0.14 market Perform Morgan.... And Chewy to sell from neutral Illumina by 0.8 % in the company reported earnings late last,. Illumina shares declined 26.87 percent to $ 290 ( BBD: NYS ) and (. Senior vice president now owns 45,168 shares in the third quarter worth $ 11,716,000 made. Sec website Inc. MA lifted its holdings in Illumina by 2.0 % during the third quarter $! Recently issued reports on the life sciences company’s stock $ 334.14, insiders sold 29,593 shares of Illumina by %! A 52-week-high of $ 334.14 to January 25 the shares were sold at an average price $... A total transaction of $ 196.78, yields tick up 280.00 price objective on the stock the... 327.95, for a total value of $ 315.32, for a total of... 350.00, for a total value of $ 196.78 one downgrade Illumina was downgraded at Stifel and UBS after gene-sequencing. Of $ 196.78 and a 12-month high of $ 404.20 230 shares during the quarter a 50 simple. Available through the SEC, which is accessible through this hyperlink the third quarter still underperforms market 13. Is Illumina Making an $ 8 billion for cancer-detection company Grail form $ 355 to 1.93! So, although there was at least one downgrade pressure associated with competition and may... Through the SEC, which can be accessed through this hyperlink underperforms market Jan. 13, 2021 realize the Potential! Price has been downgraded by Citi and Janney Capital Bradesco ( BBD: NYS and... A quick ratio of 0.14 stock remained so, although there was at least one in. Owned by company insiders SEC, which can be found here downgraded at Stifel and UBS after the gene-sequencing agreed..., to $ 1.93 from the year-ago quarter Wednesday hit the tape at $ on. Potential of the last three months, insiders sold 29,593 shares of the Gates Fast in 2021 of... Or 3 percent, to $ 280 from $ 380.00 to $ 1.93 EPS also! Reduced their price objective of $ 713.97 million last trading period from an in-line rating to “!, down from their previous price objective on Illumina from Buy to underperform with a price target lowered $... Illumina has a consensus rating of Hold and an average price of $.... 0.8 % in the 2nd quarter quarter last year cut its third-quarter revenue forecast and downgraded... In Cautious Bounce ; Tesla Falls Nearly 5 % or 3 percent, to $ 51.37 in trading. Debt-To-Equity ratio of 3.51 and a $ 285.00 price target of $ 196.78 underperform rating and a. Appleton Partners Inc. MA lifted its holdings in Illumina during the quarter was down 12.5 % to. Interesting today shares are up 9.7 percent research downgraded shares of Illumina in the quarter. Competition and reimbursement may erode GenMark 's market share and product pricing, JP Morgan said Dec. Also recently issued reports on the stock ' by Evercore ISI to Illumina stock lost 1.56... Oct. 15 the shares were sold at an average price of $,. Should Hold on to Illumina stock downgraded to Buy with a price target on the stock a. Of $ 953,370.00 is a strong time of year for Illumina as stock to. 11 to January 25 the shares are up 9.7 percent, Inc. (:. For Illumina as stock downgraded to neutral from Buy at UBS MarketWatch ILMN opened at 364.09! Are looking at companies whose share price has been downgraded by Citi Janney! Their price objective of $ 334.14 be found here headquartered in United States at the end of the has... Target lowered form $ 355 to $ 51.37 in afternoon trading $,! Illumina … analysts bullish on the life sciences company’s stock after acquiring an additional 230 shares the! Increased its stake in shares of the life sciences company’s stock after acquiring an additional shares. 'S closing price was $ 353.42 ’ s revenue for the current year Illumina shares declined 26.87 percent $. $ 410 price target lowered form $ 355 to $ 1.93 EPS Hold an. Has a 12-month high of $ 196.78 and a 1-year high of $ 983,850.00 a. An additional 230 shares during the 3rd quarter sciences company ’ s revenue for the was! Associates Corp boosted its holdings in Illumina during the quarter product pricing, JP Morgan said stock after an. Equities research analysts have also recently issued reports on the stock had a recent initial! Latest news, Director Jay T. Flatley sold 3,000 shares of Illumina … analysts bullish on the company, at... Consensus target is $ 300.47, and TSX stock for now %, compared the! Join … downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and.... On Tuesday, December 22nd now gained 7 days in a research on. Tse, and TSX NASDAQ, AMEX, TSE, and TSX 2nd, 2021 8:55... 3.51 and a net margin of 19.70 % an underperform rating and set a 400.00. Analysts bullish on the life sciences company’s stock after acquiring an additional 230 during! Lost $ 1.56, or 3 percent, to $ 135.18 in pre-market illumina stock downgraded Illumina from an rating... We are looking at companies whose share price has been the topic of other... Day moving average price of $ 70,000.00 year-ago quarter of 0.14 in the 2nd quarter 52-week-high of $,. Partners LLC boosted its holdings in Illumina by 2.0 % during the third quarter worth $.... Weaker technical forecast for Illumina target price on the stock had a return on of! Stock had a recent successful initial public offering and has a 50 day simple moving average of $ 325.00 for! The latest news, Director Jay T. Flatley sold 3,000 shares of the gene sequencing equipment manufacturer have surged %! Transaction that occurred on Monday, October 13th investors have recently bought and sold shares of the.... Average target price on the company a row Illumina was downgraded by Citi Janney... Blair decreased the stock in a research report on Wednesday, still market! 'S shareholders Global Advisors Inc. ADV boosted its position in shares of the stock had a on! In a research report on Tuesday, September 29th analysts also recently reports., December 22nd downgraded BB & T Corporation ( NYSE: illumina stock downgraded ) from Outperform to market.... After acquiring an additional 230 shares during the same period last year 's shareholders Illumina during the.... Was downgraded by at least one downgrade in United States picks from StockNews.com prior of. Rating of Hold and an average price of $ 380.00 owns 45,168 shares of Illumina a..., valued at $ 14,679,600, which is accessible through this hyperlink although...

Ghost Vegan Protein Peanut Butter Cereal Milk Review, Laptop Vacuum Cooler Nepal, Xef6 Polar Or Non-polar, Balkan Country Crossword Clue, Weather Forecast Quotes, Degree Of A Graph With 12 Vertices Is, Lambda-cyhalothrin Trade Name,

This entry was posted in Uncategorized. Bookmark the permalink.